CINDY BROWN: Open Payments
NPI 1265693881 · MAYER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$648 in 30 payments from 14 companies in 2025. Trend: 2023 $669 · 2024 $950 · 2025 $648
Food & beverage: $648
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 5 | $125 |
| Otsuka America Pharmaceutical, Inc. | 4 | $104 |
| E.R. Squibb & Sons, L.L.C. | 3 | $61 |
| Exact Sciences Corporation | 2 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| ABBVIE INC. | 3 | $51 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $24 |
| Tonix Medicines, Inc. | 1 | $22 |
Products named: SUBLOCADE, ABILIFY MAINTENA, COBENFY, The Cologuard Plus Collection Kit, CAPLYTA, TRELEGY ELLIPTA, Kerendia, JOURNAVX.
Industry payments across AZ — which companies pay providers there.
